Skip to main content
Erschienen in: Abdominal Radiology 6/2016

23.04.2016

Inherited renal carcinomas

verfasst von: Akira Kawashima, Scott W. Young, Naoki Takahashi, Bernard F. King, Thomas D. Atwell

Erschienen in: Abdominal Radiology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Hereditary forms of kidney carcinoma account for 5–8% of all malignant kidney neoplasms. The renal tumors are often multiple and bilateral and occur at an earlier age. Each of the hereditary kidney carcinoma syndromes is associated with specific gene mutations as well as a specific histologic type of kidney carcinoma. The presence of associated extrarenal manifestations may suggest a hereditary kidney cancer syndrome. Radiology is most commonly used to screen and manage patients with hereditary kidney cancer syndromes. This manuscript reviews the clinical and imaging findings of well-defined inherited kidney cancer syndromes including von Hippel–Lindau disease, Birt–Hogg–Dubé syndrome, hereditary papillary renal carcinoma syndrome, hereditary leiomyomatosis and RCC syndrome, tuberous sclerosis complex, and Lynch syndrome.
Literatur
2.
Zurück zum Zitat Shuch B, Vourganti S, Ricketts CJ, et al. (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 32(5):431–437CrossRefPubMedPubMedCentral Shuch B, Vourganti S, Ricketts CJ, et al. (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 32(5):431–437CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Coleman JA, Russo P (2009) Hereditary and familial kidney cancer. Curr Opin Urol. 19(5):478–485CrossRefPubMed Coleman JA, Russo P (2009) Hereditary and familial kidney cancer. Curr Opin Urol. 19(5):478–485CrossRefPubMed
4.
Zurück zum Zitat Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 178(6):1499–1506CrossRefPubMed Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 178(6):1499–1506CrossRefPubMed
5.
Zurück zum Zitat Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26(6):1795–1806; discussion 806-10 Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26(6):1795–1806; discussion 806-10
6.
Zurück zum Zitat Vikram R, Sandler CM, Ng CS (2009) Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol. 192(6):1488–1493CrossRefPubMed Vikram R, Sandler CM, Ng CS (2009) Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol. 192(6):1488–1493CrossRefPubMed
7.
Zurück zum Zitat Alshumrani G, O’Malley M, Ghai S, et al. (2010) Small (<or = 4 cm) cortical renal tumors: characterization with multidetector CT. Abdom Imaging. 35(4):488–493CrossRefPubMed Alshumrani G, O’Malley M, Ghai S, et al. (2010) Small (<or = 4 cm) cortical renal tumors: characterization with multidetector CT. Abdom Imaging. 35(4):488–493CrossRefPubMed
8.
Zurück zum Zitat Sasiwimonphan K, Takahashi N, Leibovich BC, et al. (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 263(1):160–168CrossRefPubMed Sasiwimonphan K, Takahashi N, Leibovich BC, et al. (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 263(1):160–168CrossRefPubMed
9.
Zurück zum Zitat Vargas HA, Chaim J, Lefkowitz RA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology. 264(3):779–788CrossRefPubMed Vargas HA, Chaim J, Lefkowitz RA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology. 264(3):779–788CrossRefPubMed
10.
Zurück zum Zitat Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 265(2):468–477CrossRefPubMedPubMedCentral Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 265(2):468–477CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 267(2):444–453CrossRefPubMed Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology. 267(2):444–453CrossRefPubMed
12.
Zurück zum Zitat Wehrli NE, Kim MJ, Matza BW, et al. (2013) Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma. AJR Am J Roentgenol. 201(6):1260–1267CrossRefPubMed Wehrli NE, Kim MJ, Matza BW, et al. (2013) Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma. AJR Am J Roentgenol. 201(6):1260–1267CrossRefPubMed
13.
Zurück zum Zitat Sasaguri K, Takahashi N, Gomez-Cardona D, et al. (2015) Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol. 205(5):999–1007CrossRefPubMed Sasaguri K, Takahashi N, Gomez-Cardona D, et al. (2015) Small (<4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol. 205(5):999–1007CrossRefPubMed
14.
Zurück zum Zitat Hotker AM, Mazaheri Y, Wibmer A, et al. (2016) Use of DWI in the differentiation of renal cortical tumors. AJR Am J Roentgenol. 206(1):100–105CrossRefPubMed Hotker AM, Mazaheri Y, Wibmer A, et al. (2016) Use of DWI in the differentiation of renal cortical tumors. AJR Am J Roentgenol. 206(1):100–105CrossRefPubMed
15.
Zurück zum Zitat Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003) Hereditary renal cancers. Radiology. 226(1):33–46CrossRefPubMed Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003) Hereditary renal cancers. Radiology. 226(1):33–46CrossRefPubMed
16.
Zurück zum Zitat Choudhary S, Sudarshan S, Choyke PL, Prasad SR (2009) Renal cell carcinoma: recent advances in genetics and imaging. Semin Ultrasound CT MR. 30(4):315–325CrossRefPubMed Choudhary S, Sudarshan S, Choyke PL, Prasad SR (2009) Renal cell carcinoma: recent advances in genetics and imaging. Semin Ultrasound CT MR. 30(4):315–325CrossRefPubMed
17.
Zurück zum Zitat Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V (2015) Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 204(5):1031–1041CrossRefPubMed Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V (2015) Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 204(5):1031–1041CrossRefPubMed
18.
Zurück zum Zitat Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol. 170(6 Pt 1):2163–2172CrossRefPubMed Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol. 170(6 Pt 1):2163–2172CrossRefPubMed
19.
Zurück zum Zitat Richard S, Gardie B, Couve S, Gad S (2013) Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 23(1):26–37CrossRefPubMed Richard S, Gardie B, Couve S, Gad S (2013) Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol. 23(1):26–37CrossRefPubMed
20.
Zurück zum Zitat Lonser RR, Glenn GM, Walther M, et al. (2003) von Hippel-Lindau disease. Lancet. 361(9374):2059–2067CrossRefPubMed Lonser RR, Glenn GM, Walther M, et al. (2003) von Hippel-Lindau disease. Lancet. 361(9374):2059–2067CrossRefPubMed
21.
Zurück zum Zitat Ho TH, Jonasch E (2014) Genetic kidney cancer syndromes. J Natl Compr Canc Netw. 12(9):1347–1355PubMed Ho TH, Jonasch E (2014) Genetic kidney cancer syndromes. J Natl Compr Canc Netw. 12(9):1347–1355PubMed
22.
Zurück zum Zitat Mester JL, Zhou M, Prescott N, Eng C (2012) Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology 79(5):1187 e1–e7 Mester JL, Zhou M, Prescott N, Eng C (2012) Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology 79(5):1187 e1–e7
23.
Zurück zum Zitat Verine J, Pluvinage A, Bousquet G, et al. (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 58(5):701–710CrossRefPubMed Verine J, Pluvinage A, Bousquet G, et al. (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 58(5):701–710CrossRefPubMed
25.
Zurück zum Zitat Joly D, Mejean A, Correas JM, et al. (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol. 185(6):2056–2060CrossRefPubMed Joly D, Mejean A, Correas JM, et al. (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol. 185(6):2056–2060CrossRefPubMed
26.
Zurück zum Zitat Park BK, Kim CK, Park SY, Shen SH (2013) Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol. 54(4):418–427CrossRefPubMed Park BK, Kim CK, Park SY, Shen SH (2013) Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes. Acta Radiol. 54(4):418–427CrossRefPubMed
27.
Zurück zum Zitat Yang B, Autorino R, Remer EM, et al. (2013) Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up. Urol Oncol. 31(5):686–692CrossRefPubMed Yang B, Autorino R, Remer EM, et al. (2013) Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up. Urol Oncol. 31(5):686–692CrossRefPubMed
28.
Zurück zum Zitat Menko FH, van Steensel MA, Giraud S, et al. (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 10(12):1199–1206CrossRefPubMed Menko FH, van Steensel MA, Giraud S, et al. (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 10(12):1199–1206CrossRefPubMed
29.
Zurück zum Zitat Adeniran AJ, Shuch B, Humphrey PA (2015) Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 39(12):e1–e18CrossRefPubMed Adeniran AJ, Shuch B, Humphrey PA (2015) Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 39(12):e1–e18CrossRefPubMed
30.
Zurück zum Zitat Pavlovich CP, Grubb RL 3rd, Hurley K, et al. (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol. 173(5):1482–1486CrossRefPubMed Pavlovich CP, Grubb RL 3rd, Hurley K, et al. (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol. 173(5):1482–1486CrossRefPubMed
31.
Zurück zum Zitat Zbar B, Tory K, Merino M, et al. (1994) Hereditary papillary renal cell carcinoma. J Urol. 151(3):561–566PubMed Zbar B, Tory K, Merino M, et al. (1994) Hereditary papillary renal cell carcinoma. J Urol. 151(3):561–566PubMed
33.
Zurück zum Zitat Chen YB, Brannon AR, Toubaji A, et al. (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 38(5):627–637CrossRefPubMedPubMedCentral Chen YB, Brannon AR, Toubaji A, et al. (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol. 38(5):627–637CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Merino MJ, Torres-Cabala C, Pinto P, Linehan WM (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 31(10):1578–1585CrossRefPubMed Merino MJ, Torres-Cabala C, Pinto P, Linehan WM (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 31(10):1578–1585CrossRefPubMed
35.
Zurück zum Zitat Grubb RL, 3rd, Franks ME, Toro J, et al. (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074–2079; discussion 9-80. Grubb RL, 3rd, Franks ME, Toro J, et al. (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074–2079; discussion 9-80.
36.
Zurück zum Zitat Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med. 355(13):1345–1356CrossRefPubMed Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med. 355(13):1345–1356CrossRefPubMed
38.
Zurück zum Zitat Jinzaki M, Tanimoto A, Narimatsu Y, et al. (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology. 205(2):497–502CrossRefPubMed Jinzaki M, Tanimoto A, Narimatsu Y, et al. (1997) Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology. 205(2):497–502CrossRefPubMed
39.
Zurück zum Zitat Froemming AT, Boland J, Cheville J, Takahashi N, Kawashima A (2013) Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol. 200(2):W178–W186CrossRefPubMed Froemming AT, Boland J, Cheville J, Takahashi N, Kawashima A (2013) Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. AJR Am J Roentgenol. 200(2):W178–W186CrossRefPubMed
40.
Zurück zum Zitat Tsukada J, Jinzaki M, Yao M, et al. (2013) Epithelioid angiomyolipoma of the kidney: radiological imaging. Int J Urol. 20(11):1105–1111CrossRefPubMed Tsukada J, Jinzaki M, Yao M, et al. (2013) Epithelioid angiomyolipoma of the kidney: radiological imaging. Int J Urol. 20(11):1105–1111CrossRefPubMed
41.
Zurück zum Zitat Mork M, Hubosky SG, Roupret M, et al. (2015) Lynch syndrome: a primer for urologists and panel recommendations. J Urol. 194(1):21–29CrossRefPubMed Mork M, Hubosky SG, Roupret M, et al. (2015) Lynch syndrome: a primer for urologists and panel recommendations. J Urol. 194(1):21–29CrossRefPubMed
42.
Zurück zum Zitat Goecke T, Schulmann K, Engel C, et al. (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 24(26):4285–4292CrossRefPubMed Goecke T, Schulmann K, Engel C, et al. (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol. 24(26):4285–4292CrossRefPubMed
43.
Zurück zum Zitat Roupret M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 54(6):1226–1236CrossRefPubMed Roupret M, Yates DR, Comperat E, Cussenot O (2008) Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Eur Urol. 54(6):1226–1236CrossRefPubMed
44.
Zurück zum Zitat Crockett DG, Wagner DG, Holmang S, Johansson SL, Lynch HT (2011) Upper urinary tract carcinoma in Lynch syndrome cases. J Urol. 185(5):1627–1630CrossRefPubMed Crockett DG, Wagner DG, Holmang S, Johansson SL, Lynch HT (2011) Upper urinary tract carcinoma in Lynch syndrome cases. J Urol. 185(5):1627–1630CrossRefPubMed
45.
Zurück zum Zitat Kawashima A, Vrtiska TJ, LeRoy AJ, et al. (2004) CT urography. Radiographics. 24(Suppl 1):S35–S54; discussion S5-8. Kawashima A, Vrtiska TJ, LeRoy AJ, et al. (2004) CT urography. Radiographics. 24(Suppl 1):S35–S54; discussion S5-8.
46.
Zurück zum Zitat Hubosky SG, Boman BM, Charles S, Bibbo M, Bagley DH (2013) Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome). BJU Int. 112(6):813–819CrossRefPubMed Hubosky SG, Boman BM, Charles S, Bibbo M, Bagley DH (2013) Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome). BJU Int. 112(6):813–819CrossRefPubMed
Metadaten
Titel
Inherited renal carcinomas
verfasst von
Akira Kawashima
Scott W. Young
Naoki Takahashi
Bernard F. King
Thomas D. Atwell
Publikationsdatum
23.04.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0743-6

Weitere Artikel der Ausgabe 6/2016

Abdominal Radiology 6/2016 Zur Ausgabe

Classics in Abdominal Imaging

The “watering can perineum”

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.